UBS Group’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$580K Sell
10,709
-4,003
-27% -$263K ﹤0.01% 5978
2025
Q4
$904K Sell
14,712
-262
-2% -$16.9K ﹤0.01% 5660
2025
Q3
$1.09M Sell
14,974
-11,282
-43% -$889K ﹤0.01% 5499
2025
Q2
$1.95M Buy
26,256
+15,680
+148% +$1.1M ﹤0.01% 4850
2025
Q1
$793K Sell
10,576
-39,969
-79% -$3.71M ﹤0.01% 5479
2024
Q4
$5.16M Buy
50,545
+44,147
+690% +$5.06M ﹤0.01% 3814
2024
Q3
$674K Buy
6,398
+1,247
+24% +$127K ﹤0.01% 4988
2024
Q2
$480K Sell
5,151
-5,627
-52% -$597K ﹤0.01% 5034
2024
Q1
$1.4M Sell
10,778
-14,921
-58% -$1.75M ﹤0.01% 4298
2023
Q4
$2.91M Buy
25,699
+13,764
+115% +$1.19M ﹤0.01% 3409
2023
Q3
$980K Sell
11,935
-271
-2% -$23.8K ﹤0.01% 4091
2023
Q2
$1.14M Sell
12,206
-60,763
-83% -$4.86M ﹤0.01% 4122
2023
Q1
$4.96M Buy
72,969
+3,455
+5% +$279K ﹤0.01% 2529
2022
Q4
$4.94M Buy
69,514
+68,920
+11,603% +$4.7M ﹤0.01% 2515
2022
Q3
$37K Buy
594
+89
+18% +$6.41K ﹤0.01% 6629
2022
Q2
$34K Sell
505
-192
-28% -$14.4K ﹤0.01% 6248
2022
Q1
$50K Sell
697
-1,799
-72% -$147K ﹤0.01% 6492
2021
Q4
$239K Buy
2,496
+2,266
+985% +$153K ﹤0.01% 5536
2021
Q3
$11K Sell
230
-1,234
-84% -$62K ﹤0.01% 7864
2021
Q2
$74K Buy
1,464
+371
+34% +$18.3K ﹤0.01% 6100
2021
Q1
$43K Buy
1,093
+516
+89% +$20.1K ﹤0.01% 6696
2020
Q4
$16K Buy
577
+327
+131% +$8.36K ﹤0.01% 7097
2020
Q3
$5K Sell
250
-810
-76% -$13.1K ﹤0.01% 7291
2020
Q2
$9K Buy
1,060
+478
+82% +$2.95K ﹤0.01% 7064
2020
Q1
$3K Sell
582
-41,008
-99% -$461K ﹤0.01% 7470
2019
Q4
$593K Buy
41,590
+34,330
+473% +$704K ﹤0.01% 4675
2019
Q3
$235K Buy
+7,260
New +$183K ﹤0.01% 5116
2019
Q2
Sell
-1,260
Closed -$34K 7863
2019
Q1
$34K Sell
1,260
-2,782
-69% -$79.1K ﹤0.01% 5829
2018
Q4
$100K Buy
4,042
+1,891
+88% +$46.4K ﹤0.01% 5544
2018
Q3
$68K Buy
2,151
+1,114
+107% +$40.1K ﹤0.01% 5914
2018
Q2
$39K Buy
+1,037
New +$40.5K ﹤0.01% 6185
2017
Q3
Sell
-2,141
Closed -$23K 7726
2017
Q2
$23K Buy
2,141
+945
+79% +$9.4K ﹤0.01% 6183
2017
Q1
$11K Buy
1,196
+1,091
+1,039% +$7.85K ﹤0.01% 6543
2016
Q4
$1K Sell
105
-1,113
-91% -$8.84K ﹤0.01% 7604
2016
Q3
$11K Sell
1,218
-2,907
-70% -$24K ﹤0.01% 6711
2016
Q2
$29K Buy
4,125
+3,681
+829% +$26K ﹤0.01% 5958
2016
Q1
$3K Buy
+444
New +$1.9K ﹤0.01% 7179
2015
Q4
Sell
-327
Closed -$2K 8345
2015
Q3
$2K Buy
+327
New +$2.91K ﹤0.01% 8063
2015
Q2
Sell
-201
Closed -$2K 8498
2015
Q1
$2K Sell
201
-469
-70% -$5.04K ﹤0.01% 8429
2014
Q4
$8K Buy
+670
New +$7.95K ﹤0.01% 8567

Other funds holding BXC

UBS Group's BXC Position: Q1 2026 in Review

UBS Group reduced its BlueLinx (BXC) stake by 27% in Q1 2026, selling an estimated $263K and leaving 10,709 shares worth $580K. The position accounts for ﹤0.01% of the portfolio, ranked #5978.

UBS Group first reported a position in BXC in Q4 2014 and has held it in 40 quarters since. The position peaked at $5.16M in Q4 2024. 145 funds tracked by Wall St. Rank hold BXC as of Q1 2026.

  • UBS Group held 10,709 shares of BlueLinx worth $580K as of Q1 2026.
  • UBS Group sold 4,003 BlueLinx shares in Q1 2026, an estimated $263K.
  • BlueLinx made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5978 holding.
  • UBS Group first reported a position in BlueLinx in Q4 2014 and has held it in 40 quarters since.
  • UBS Group's BlueLinx position peaked at $5.16M in Q4 2024.
  • 145 funds tracked by Wall St. Rank held BlueLinx as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.